GUANGDONG JIAYING PHARMACEUTICAL CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.7 CNY | +0.15% |
|
+0.90% | -7.97% |
| Sales 2021 | 575M 79.3M | Sales 2022 | 659M 90.96M | Capitalization | 3.31B 457M |
|---|---|---|---|---|---|
| Net income 2021 | 1M 138K | Net income 2022 | 43M 5.93M | EV / Sales 2021 | 6.59 x |
| Net cash position 2021 | 212M 29.22M | Net cash position 2022 | 236M 32.56M | EV / Sales 2022 | 4.66 x |
| P/E ratio 2021 |
2,717
x | P/E ratio 2022 |
75.3
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 64.29% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.15% | ||
| 1 week | +0.90% | ||
| Current month | +2.60% | ||
| 1 month | -0.15% | ||
| 3 months | +9.30% | ||
| 6 months | +5.68% | ||
| Current year | -7.97% |
1 week
6.52
6.83
1 month
6.277.38
Current year
4.677.43
1 year
4.679.15
3 years
4.4211.00
5 years
3.9211.00
10 years
3.9220.88
| Managers | Title | Age | Since |
|---|---|---|---|
Jie Feng
DFI | Director of Finance/CFO | 38 | 21-10-14 |
La Yi Zhu
CHM | Chairman | 67 | 21-08-01 |
Gao Hua Zhong
BRD | Director/Board Member | 43 | 11-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yi Cai Lai
BRD | Director/Board Member | 61 | 19-05-15 |
Hua Ping Guo
BRD | Director/Board Member | 61 | 21-05-30 |
Xiao Liang Huang
BRD | Director/Board Member | 44 | 21-07-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 6.7 | +0.15% | 9,835,800 |
| 24-04-23 | 6.69 | +0.45% | 8,810,867 |
| 24-04-22 | 6.66 | 0.00% | 2,396,500 |
| 24-04-19 | 6.66 | +1.22% | 3,064,000 |
| 24-04-18 | 6.58 | -0.90% | 2,964,637 |
End-of-day quote Shenzhen S.E., April 23, 2024
More quotes
GUANGDONG JIAYING PHARMACEUTICAL CO., LTD is a China-based company principally engaged in the research, development, manufacture and sales of Chinese patent medicine. The Companyâs main products include Chinese traditional preparations, powders, tablets, capsules and granules, which are mainly applied in the treatment of throat disease, cold, stomach disease and others, as well as for tonic nourish purpose and others. The Company distributes its products mainly in domestic market. Through its subsidiaries, the Company is also engaged in the operation and leasing of self-owned real estate.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q4 2023 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.97% | 469M | |
| +38.08% | 6.05B | |
| -16.43% | 4.45B | |
| -12.46% | 3.06B | |
| -0.21% | 3.04B | |
| -0.59% | 2.58B | |
| +34.54% | 1.79B | |
| +0.93% | 1.66B | |
| -10.63% | 1.63B | |
| -12.50% | 1.54B |
- Stock Market
- Equities
- 002198 Stock
